Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
26
EFGSY Quote, Financials, Valuation and Earnings
Last price:
$27.23
Seasonality move
:
-4.94%
Day range:
$26.50 - $27.21
52-week range:
$16.54 - $29.00
Dividend yield:
4.01%
P/E ratio:
11.95x
P/S ratio:
0.49x
P/B ratio:
1.75x
Volume:
1.1K
Avg. volume:
1.2K
1-year change:
34.2%
Market cap:
$12.2B
Revenue:
$26B
EPS (TTM):
$2.33
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $19B | $22.7B | $22B | $24.2B | $26B | |
| Revenue Growth (YoY) | -9.09% | 19.44% | -3.09% | 10.05% | 7.35% | |
| Cost of Revenues | $3.3B | $3.8B | $3.8B | $4.3B | $4.3B | |
| Gross Profit | $15.7B | $19B | $18.2B | $20B | $21.8B | |
| Gross Profit Margin | 82.53% | 83.39% | 82.77% | 82.37% | 83.6% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $14.3B | $16.8B | $15.9B | $17.4B | $19.2B | |
| Operating Income | $1.4B | $2.1B | $2.3B | $2.6B | $2.6B | |
| Net Interest Expenses | $309.5M | $315.9M | $347M | $341M | $358.3M | |
| EBT. Incl. Unusual Items | $1.1B | $1.9B | $1.9B | $2.2B | $2.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $376.9M | $515.9M | $517.8M | $588.9M | $662.4M | |
| Net Income to Company | $701.2M | $1.4B | $1.4B | $1.7B | $1.6B | |
| Minority Interest in Earnings | -$272.9M | -$462.6M | -$484.1M | -$561.9M | -$521.7M | |
| Net Income to Common Excl Extra Items | $428.3M | $890.9M | $944.9M | $1.1B | $1.1B | |
| Basic EPS (Cont. Ops) | $0.87 | $1.83 | $2.00 | $2.31 | $2.40 | |
| Diluted EPS (Cont. Ops) | $0.87 | $1.81 | $1.97 | $2.28 | $2.37 | |
| Weighted Average Basic Share | $489.3M | $487M | $473.7M | $475.3M | $470.3M | |
| Weighted Average Diluted Share | $493.3M | $492.2M | $478.9M | $480.7M | $475.8M | |
| EBITDA | $2.8B | $3.7B | $3.6B | $4.2B | $4.4B | |
| EBIT | $1.4B | $2.2B | $2.3B | $2.7B | $2.8B | |
| Revenue (Reported) | $19B | $22.7B | $22B | $24.2B | $26B | |
| Operating Income (Reported) | $1.4B | $2.1B | $2.3B | $2.6B | $2.6B | |
| Operating Income (Adjusted) | $1.4B | $2.2B | $2.3B | $2.7B | $2.8B | |
| Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $19.2B | $22.5B | $21.8B | $24.3B | $25.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.4B | $3.7B | $3.8B | $4.3B | $4.2B | |
| Gross Profit | $15.9B | $18.8B | $18B | $20B | $21.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $14.5B | $16.7B | $15.8B | $17.4B | $19B | |
| Operating Income | $1.4B | $2.1B | $2.3B | $2.6B | $2.6B | |
| Net Interest Expenses | $310.8M | $312.4M | $342M | $341.1M | $354.6M | |
| EBT. Incl. Unusual Items | $1.1B | $1.8B | $1.9B | $2.2B | $2.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $390.3M | $507.1M | $510.8M | $588.8M | $654.9M | |
| Net Income to Company | $724.3M | $1.3B | $1.4B | $1.7B | $1.6B | |
| Minority Interest in Earnings | -$276.5M | -$456.7M | -$479.2M | -$562.2M | -$516.3M | |
| Net Income to Common Excl Extra Items | $447.8M | $876.5M | $931.3M | $1.1B | $1.1B | |
| Basic EPS (Cont. Ops) | $0.91 | $1.80 | $1.97 | $2.30 | $2.37 | |
| Diluted EPS (Cont. Ops) | $0.91 | $1.78 | $1.95 | $2.28 | $2.34 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.8B | $3.6B | $3.6B | $4.2B | $4.3B | |
| EBIT | $1.4B | $2.1B | $2.2B | $2.7B | $2.8B | |
| Revenue (Reported) | $19.2B | $22.5B | $21.8B | $24.3B | $25.7B | |
| Operating Income (Reported) | $1.4B | $2.1B | $2.3B | $2.6B | $2.6B | |
| Operating Income (Adjusted) | $1.4B | $2.1B | $2.2B | $2.7B | $2.8B | |
| Period Ending | 2021-07-17 | 2022-07-17 | 2023-07-17 | 2024-07-17 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.4B | $5.4B | $5.1B | $5.5B | $6.3B | |
| Short Term Investments | $78.7M | $67.9M | $71.9M | $77.4M | $77M | |
| Accounts Receivable, Net | $6.5B | $6.2B | $6.7B | $7.4B | $7.2B | |
| Inventory | $987.7M | $988.4M | $1.1B | $1.1B | $966.7M | |
| Prepaid Expenses | $253.4M | $276.3M | $101.9M | $127.1M | $141.5M | |
| Other Current Assets | $136.5M | $212.9M | $219.8M | $277.5M | $296.6M | |
| Total Current Assets | $16B | $15B | $15.1B | $16.3B | $17B | |
| Property Plant And Equipment | $3.5B | $3.1B | $3.2B | $3.6B | $3.7B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4.2B | $3.9B | $4B | $4.2B | $4.8B | |
| Other Intangibles | $14.6B | $13.4B | $12.6B | $13.3B | $12.3B | |
| Other Long-Term Assets | -- | -- | -- | $2.2M | $1M | |
| Total Assets | $41.5B | $38.2B | $38.8B | $41.8B | $41.9B | |
| Accounts Payable | $4.8B | $4.6B | $5.2B | $5.7B | $5.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $284.1M | $327.2M | $312.1M | $359.3M | $354.8M | |
| Other Current Liabilities | -- | -- | -- | -- | $7B | |
| Total Current Liabilities | $15.4B | $14.3B | $15.5B | $16.2B | $17.7B | |
| Long-Term Debt | $14.8B | $13.4B | $12.7B | $13.9B | $12.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $33.5B | $30.5B | $30.9B | $33B | $33.5B | |
| Common Stock | $482.1M | $443.8M | $420.4M | $433.3M | $407.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $6.5B | $6.2B | $6.6B | $7.1B | $7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.4B | $1.4B | $1.3B | $1.6B | $1.5B | |
| Total Equity | $8B | $7.6B | $8B | $8.8B | $8.5B | |
| Total Liabilities and Equity | $41.5B | $38.2B | $38.8B | $41.8B | $41.9B | |
| Cash and Short Terms | $6.5B | $5.5B | $5.2B | $5.5B | $6.3B | |
| Total Debt | $18.9B | $16.2B | $16B | $16.4B | $16.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.4B | $5.4B | $5.1B | $5.5B | $6.3B | |
| Short Term Investments | $78.7M | $67.9M | $71.9M | $77.4M | $77M | |
| Accounts Receivable, Net | $6.5B | $6.2B | $6.7B | $7.4B | $7.2B | |
| Inventory | $987.7M | $988.4M | $1.1B | $1.1B | $966.7M | |
| Prepaid Expenses | $253.4M | $276.3M | $101.9M | $127.1M | $141.5M | |
| Other Current Assets | $136.5M | $212.9M | $219.8M | $277.5M | $296.6M | |
| Total Current Assets | $16B | $15B | $15.1B | $16.3B | $17B | |
| Property Plant And Equipment | $3.5B | $3.1B | $3.2B | $3.6B | $3.7B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4.2B | $3.9B | $4B | $4.2B | $4.8B | |
| Other Intangibles | $14.6B | $13.4B | $12.6B | $13.3B | $12.3B | |
| Other Long-Term Assets | -- | -- | -- | $2.2M | $1M | |
| Total Assets | $41.5B | $38.2B | $38.8B | $41.8B | $41.9B | |
| Accounts Payable | $4.8B | $4.6B | $5.2B | $5.7B | $5.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $284.1M | $327.2M | $312.1M | $359.3M | $354.8M | |
| Other Current Liabilities | -- | -- | -- | -- | $7B | |
| Total Current Liabilities | $15.4B | $14.3B | $15.5B | $16.2B | $17.7B | |
| Long-Term Debt | $14.8B | $13.4B | $12.7B | $13.9B | $12.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $33.5B | $30.5B | $30.9B | $33B | $33.5B | |
| Common Stock | $482.1M | $443.8M | $420.4M | $433.3M | $407.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.4B | $1.4B | $1.3B | $1.6B | $1.5B | |
| Total Equity | $8B | $7.6B | $8B | $8.8B | $8.5B | |
| Total Liabilities and Equity | $41.5B | $38.2B | $38.8B | $41.8B | $41.9B | |
| Cash and Short Terms | $6.5B | $5.5B | $5.2B | $5.5B | $6.3B | |
| Total Debt | $18.9B | $16.2B | $16B | $16.4B | $16.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $701.2M | $1.4B | $1.4B | $1.7B | $1.6B | |
| Depreciation & Amoritzation | $1.4B | $1.5B | $1.3B | $1.5B | $1.6B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$369.2M | -- | |
| Change in Inventories | -- | -- | -- | $73.6M | -- | |
| Cash From Operations | $2.5B | $3.2B | $3.1B | $3.6B | $4B | |
| Capital Expenditures | $1.1B | $1.2B | $1.1B | $939.7M | $1B | |
| Cash Acquisitions | -$22.8M | -$119.5M | -$1.5B | -$273.9M | -$873.5M | |
| Cash From Investing | -$991.3M | -$1.1B | -$2.4B | -$1B | -$1.6B | |
| Dividends Paid (Ex Special Dividend) | -$364.3M | -$733.6M | -$793.1M | -$871.5M | -$1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.1B | $728.8M | $1.4B | $1.1B | $1.5B | |
| Long-Term Debt Repaid | -$3.9B | -$1.7B | -$898.5M | -$1.8B | -$898.3M | |
| Repurchase of Common Stock | -$276.4M | -$450.8M | -$353.3M | -$361.6M | -$500M | |
| Other Financing Activities | -$263.8M | -$224.8M | -$23.2M | -$270.7M | -$119.1M | |
| Cash From Financing | -$817.7M | -$2.5B | -$777.2M | -$2.3B | -$1.2B | |
| Beginning Cash (CF) | $4.9B | $6B | $5B | $5B | $5.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $708.1M | -$408.2M | -$106.5M | $221.9M | $1.2B | |
| Ending Cash (CF) | $5.8B | $5.6B | $4.9B | $5.2B | $6.4B | |
| Levered Free Cash Flow | $1.5B | $2B | $2B | $2.7B | $3B | |
| Period Ending | 2021-07-17 | 2022-07-17 | 2023-07-17 | 2024-07-17 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $724.3M | $1.3B | $1.4B | $1.7B | $1.6B | |
| Depreciation & Amoritzation | $1.4B | $1.5B | $1.3B | $1.5B | $1.6B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.6B | $3.1B | $3B | $3.6B | $4B | |
| Capital Expenditures | $1.1B | $1.2B | $1.1B | $939.9M | $1B | |
| Cash Acquisitions | -$23.1M | -$115.3M | -$1.5B | -$272.5M | -$859.8M | |
| Cash From Investing | -$999.7M | -$1.1B | -$2.4B | -$1B | -$1.6B | |
| Dividends Paid (Ex Special Dividend) | -$361.2M | -$737.4M | -$791.5M | -$874.7M | -$1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.1B | $708.8M | $1.4B | $1.1B | $1.5B | |
| Long-Term Debt Repaid | -$3.8B | -$1.7B | -$893.5M | -$1.8B | -$893.7M | |
| Repurchase of Common Stock | -$283.8M | -$440.2M | -$354.5M | -$361.2M | -$494.4M | |
| Other Financing Activities | -$254.3M | -$217.4M | -$23.4M | -$272.6M | -$117.8M | |
| Cash From Financing | -$837.2M | -$2.5B | -$784.9M | -$2.3B | -$1.2B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $780.3M | -$455.3M | -$132.6M | $206.7M | $1.2B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.5B | $1.9B | $2B | $2.6B | $3B | |
| Period Ending | 2022-07-17 | 2023-07-17 | 2024-07-17 | 2025-07-17 | 2026-07-17 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get EFGSY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EFGSY
Sector
P/E ratio
11.95x
18.58x
PEG ratio
0.56x
0.25x
P/B ratio
1.75x
1.75x
Price / LTM sales
0.49x
0.94x
Growth Metrics
EFGSY
Sector
Revenue growth
--
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
4.45%
4.35%
Earnings forecast
--
$0.40
Profitability
EFGSY
Sector
Profitability FY 2024
$21.8B
$393.9M
Return on invested capital
4.52%
5.32%
Return on assets
2.68%
3.49%
Return on equity
12.92%
8.55%
Earnings Date
Last Earnings Date
Jul
17
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Oct
16
Balance Sheet
EFGSY
Sector
Total cash
$6.3B
$154.3M
Short term investments
$77M
$35.5M
Total assets
$41.9B
$1.7B
Long term debt
$16.1B
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
